AstraZeneca
demonstrated for factor inhibitors in | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
25 of 49
Related slides by other companies
MindMed
Investor Presentation
November 2024
phase trial schematic schematic | MindMed
Equillium
Investor Presentation
December 2023
clinically validated in severe dermatological disease | Equillium
Aeglea BioTherapeutics
Investor Presentation
May 2023
significantly and reduces plasma arginine levels in phase | Aeglea BioTherapeutics
Oculis
Results
May 2023
next step phase trial stage | Oculis
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights